Foust Warren reported grant involving 22,493 derivative units of STAAR SURGICAL CO at $0.00 for $0 on Aug 14, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
President and CEO
President and CEO
Filed Aug 18, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
22,493Restricted Stock Units
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
22,493Direct
Trade date
Aug 14, 2026Grant
Filed
Aug 18, 2026, 4:03 PM ET4-day reporting delay
Accession
0001970778-26-000014Code A · Transaction 1886
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 14, 2026Option exercise7,331$0.00$0Trade 1891
Aug 14, 2026Option exercise3,666$0.00$0Trade 1892
Aug 14, 2026Tax withholding3,730$26.18−$97,651.40Trade 1883
Aug 14, 2026Tax withholding1,865$26.18−$48,825.70Trade 1885
Aug 14, 2026Option exercise7,331$0.00$0Trade 1882
Aug 14, 2026Option exercise3,666$0.00$0Trade 1884
Aug 14, 2026Grant131,830$0.00$0Trade 1889
Aug 14, 2026Grant123,659$0.00$0Trade 1890
Aug 14, 2026Grant40,471$0.00$0Trade 1887
Aug 14, 2026Grant37,962$0.00$0Trade 1888
11 transaction rows in this filing. Joint filers share the same rows.

STAA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STAA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +16%1w ago −1.7%1d ago +2.8%
Returns since7d −6.5%30d −9.1%90d180d1y

Footnotes in full

F1: On August 14, 2026, the third tranche of 7,331 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with his annual equity grant vested, of which 3,730 shares were withheld to satisfy taxes. F2: On August 14, 2026, the third tranche of 3,666 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with his expanded role as President and Chief Operating Officer vested, of which 1,865 shares were withheld to satisfy taxes. F3: Each RSU represents the right to receive one share of the Corporation's common stock upon vesting. F4: The Reporting Person was granted Issuer restricted stock units (RSUs) on August 14, 2026 (the "Grant Date"). These RSUs vest as to 1/3 on the first anniversary of the Grant Date, and the remaining 2/3 vesting in 24 substantially equal monthly installments thereafter. F5: The Reporting Person was granted an option to purchase 40,471 shares of Company common stock. The shares underlying the option vest over three years from the Grant Date, with one-third vesting on the first anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter F6: The Reporting Person was granted an option to purchase 37,962 shares of Company common stock. The shares underlying the option vest over 42 months from the Grant Date, with one-third vesting on the 18-month anniversary of the Grant Date and the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. F7: The Reporting Person was granted a performance option to purchase 131,830 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the first anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. F8: The Reporting Person was granted a performance option to purchase 123,659 shares of Company common stock. The shares underlying the option vest over a performance period ending on the earlier of a change in control and the 10-year anniversary of the Grant Date, subject to achievement of stock-price hurdles of $50.00, $75.00 and $100.00 per share, and time vest as to one-third on the 18-month anniversary of the Grant Date with the remaining two-thirds vesting in 24 substantially equal monthly installments thereafter. F9: Represents the settlement of the third tranche of PSUs awarded to the Reporting Person in connection with his annual equity grant under the 2025 PSU Program. The number of shares was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported. F10: Represents the settlement of the third tranche of PSUs awarded under the 2025 PSU Program to the Reporting Person in connection with his expanded role as President & Chief Operating Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.